Tempest Therapeutics, Inc. (TPST) Net Income by Year
Tempest Therapeutics, Inc. reported a net loss of $26.3M in fiscal year 2025. This represents an increase of 37.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Tempest Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TPST Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$26.3M+37.2% | -$41.8M-41.9% | -$29.5M+17.4% | -$35.7M-26.2% | -$28.3M-47.3% | -$19.2M+56.9% | -$44.6M-63.9% | -$27.2M+67.8% | -$84.6M-2.8% | -$82.3M-12.3% | -$73.2M-47.9% | -$49.5M-70.5% | -$29.0M-115.0% | -$13.5M | N/A |
TPST Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Tempest Therapeutics, Inc. financials
Frequently Asked Questions
What was Tempest Therapeutics, Inc.'s net income in fiscal year 2025?
Tempest Therapeutics, Inc. reported a net loss of $26.3M in fiscal year 2025.
How fast is Tempest Therapeutics, Inc.'s net income growing?
Tempest Therapeutics, Inc. (TPST) net income rose by 37.2% year over year, from -$41.8M to -$26.3M in fiscal year 2025.
What was Tempest Therapeutics, Inc.'s net income in the most recent quarter?
Tempest Therapeutics, Inc. (TPST) reported -$5.2M in net income in Q2 2026. This represents an increase of 33.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Tempest Therapeutics, Inc. (TPST) reported on that line in every period on record.